Al's Comment:

The Japanese version of FDA granted approval of this new treatment for Glioblastomas!   The clinical trial had amazing success for recurrent Glioblastoma.  We are trying to get access here!


Posted on: 06/11/2021

Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click
HERE to read it!